Geode Capital Management, LLC Iterum Therapeutics PLC Transaction History

Geode Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	BUY	$0.31 - $0.45 $18,284 - $26,541	58,982 Added 178.12%	92,095 $32,000
Q4 2021 Feb 11, 2022	SELL	$0.39 - $0.74 $37,501 - $71,156	-96,158 Reduced 74.38%	33,113 $12,000
Q3 2021 Nov 12, 2021	BUY	$0.54 - $2.29 $15,211 - $64,507	28,169 Added 27.86%	129,271 $72,000
Q2 2021 Aug 13, 2021	BUY	$0.97 - $2.39 $4,781 - $11,780	4,929 Added 5.13%	101,102 $233,000
Q1 2021 May 12, 2021	BUY	$0.97 - $2.73 $61,168 - $172,153	63,060 Added 190.44%	96,173 $135,000
Q4 2020 Feb 12, 2021	BUY	$0.46 - $1.2 $15,231 - $39,735	33,113 New	33,113 $32,000

Ticker ITRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,233,400
Market Cap $15.9M
Description
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract inf...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.